References
- Richard MA, Corgibet F, Beylot-Barry M, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the OBJECTIFS PEAU study. J Eur Acad Dermatol Venereol. 2018;32(11):1967–1971. doi:10.1111/jdv.1495929569785
- Maccari F, Fougerousse AC, Esteve E, et al. Gem resopso and the AJDerm. Crossed looks on the dermatologist’s position and the patient’s preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN-PSO study. J Eur Acad Dermatol Venereol. 2019;33(5):880–885. doi:10.1111/jdv.1542330633377
- Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi:10.1097/00005650-199603000-000038628042
- Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg. 1998;17:291–296. doi:10.1016/S1085-5629(98)80026-69859917
- Chularojanamontri L, Griffiths CE, Chalmers RJ. The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol. 2013;133(8):1956–1962. doi:10.1038/jid.2013.13823807685
- Richard MA, Aractingi S, Joly P, et al. [French adaptation of a new score for global assessment of psoriasis severity: the Simplified Psoriasis Index (SPI)]. Ann Dermatol Venereol. 2019;146(12):783–792. doi:10.1016/j.annder.2019.08.004. original article was published in french.31623858
- Halioua B, Maccari F, Fougerousse AC, et al. Impact of patient psoriasis on partner quality of life, sexuality and empathy feelings: a study in 183 couples. J Eur Acad Dermatol Venereol. 2020;34(9):2044–2050. doi:10.1111/jdv.16270
- Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5(3):141–150. doi:10.1016/j.ijwd.2019.04.02131360745
- Bangsgaard N, Rørbye C, Skov L. Treating psoriasis during pregnancy: safety and efficacy of treatments. Am J Clin Dermatol. 2015;16(5):389–398. doi:10.1007/s40257-015-0137-526149091
- Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810. doi:10.1136/annrheumdis-2015-20884026888948
- Cacciapuoti S, Scala E, Megna M, et al. Impact of current anti-psoriatic systemic treatments on male and female fertility: what the endocrinologist needs to know. Minerva Endocrinol. 2020. doi:10.23736/S0391-1977.20.03236-8
- Scala E, Megna M, Amerio P, et al. Patients’ demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis. PLoS One. 2020;15(8):e0237267. doi:10.1371/journal.pone.023726732785291
- Lin X, Huang T. Impact of pregnancy and oestrogen on psoriasis and potential therapeutic use of selective oestrogen receptor modulators for psoriasis. J Eur Acad Dermatol Venereol. 2016;30(7):1085–1091. doi:10.1111/jdv.1366127072912